GLP1R and diabetes mellitus: Therefore, GLP-1 receptor agonists (GLP-1RAs) may potentially improve cognitive function in patients with diabetes by activating these receptors, and this effect is not limited to blood glucose control, but also includes direct neuroprotection and cognitive enhancement effects on the central nervous system.